Literature DB >> 15863836

Peptide inhibitor of pancreatic lipase selected by phage display using different elution strategies.

M Lunder1, T Bratkovic, S Kreft, B Strukelj.   

Abstract

Interference with fat hydrolysis results in the reduced use of ingested lipids. Inhibition of pancreatic lipase reduces the efficiency of fat absorption in the small intestine and thereby initiates modest long-term reduction in body weight. In an attempt to select peptides with affinity for the surface of pancreatic lipase and potential inhibitory activity, a random, cyclic heptapeptide phage-displayed library was used. Five independent selections, differing in elution step, were performed. In three selection protocols, a sequential elution strategy was applied in anticipation of improving the selection of high-affinity clones. Four heptapeptides with the highest affinity, seemingly for pancreatic lipase, were selected, synthesized, and characterized for their capacity to inhibit enzyme function. Although no clear consensus among the sequenced peptides was found, one of the selected peptides inhibited pancreatic lipase with an apparent inhibition constant of 16 muM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15863836     DOI: 10.1194/jlr.M500048-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

1.  Potential of phage-displayed peptide library technology to identify functional targeting peptides.

Authors:  Lauren Rh Krumpe; Toshiyuki Mori
Journal:  Expert Opin Drug Discov       Date:  2007-04       Impact factor: 6.098

Review 2.  Progress in phage display: evolution of the technique and its application.

Authors:  Tomaz Bratkovic
Journal:  Cell Mol Life Sci       Date:  2010-03       Impact factor: 9.261

3.  Characteristics of New Peptides GQLGEHGGAGMG, GEHGGAGMGGGQFQPV, EQGFLPGPEESGR, RLARAGLAQ, YGNPVGGVGH, and GNPVGGVGHGTTGT as Inhibitors of Enzymes Involved in Metabolic Syndrome and Antimicrobial Potential.

Authors:  Urszula Złotek; Anna Jakubczyk; Kamila Rybczyńska-Tkaczyk; Paula Ćwiek; Barbara Baraniak; Sławomir Lewicki
Journal:  Molecules       Date:  2020-05-27       Impact factor: 4.411

Review 4.  Current Trends of Bioactive Peptides-New Sources and Therapeutic Effect.

Authors:  Anna Jakubczyk; Monika Karaś; Kamila Rybczyńska-Tkaczyk; Ewelina Zielińska; Damian Zieliński
Journal:  Foods       Date:  2020-06-29

5.  The Effect of Steaming and Fermentation on Nutritive Values, Antioxidant Activities, and Inhibitory Properties of Tea Leaves.

Authors:  Chaowanee Chupeerach; Amornrat Aursalung; Thareerat Watcharachaisoponsiri; Kanyawee Whanmek; Parunya Thiyajai; Kachakot Yosphan; Varittha Sritalahareuthai; Yuraporn Sahasakul; Chalat Santivarangkna; Uthaiwan Suttisansanee
Journal:  Foods       Date:  2021-01-08

Review 6.  Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields.

Authors:  Antonio Moretta; Carmen Scieuzo; Anna Maria Petrone; Rosanna Salvia; Michele Dario Manniello; Antonio Franco; Donatella Lucchetti; Antonio Vassallo; Heiko Vogel; Alessandro Sgambato; Patrizia Falabella
Journal:  Front Cell Infect Microbiol       Date:  2021-06-14       Impact factor: 5.293

7.  Selection of new diagnostic markers for Dirofilaria repens infections with the use of phage display technology.

Authors:  Mateusz Pękacz; Katarzyna Basałaj; Alicja Kalinowska; Maciej Klockiewicz; Diana Stopka; Piotr Bąska; Ewa Długosz; Justyna Karabowicz; Daniel Młocicki; Marcin Wiśniewski; Anna Zawistowska-Deniziak
Journal:  Sci Rep       Date:  2022-02-10       Impact factor: 4.379

8.  Chromato-panning: an efficient new mode of identifying suitable ligands from phage display libraries.

Authors:  Wim Noppe; Fatima Plieva; Igor Yu Galaev; Hans Pottel; Hans Deckmyn; Bo Mattiasson
Journal:  BMC Biotechnol       Date:  2009-03-17       Impact factor: 2.563

9.  Peptide modulators of alpha-glucosidase.

Authors:  Irena Roskar; Peter Molek; Miha Vodnik; Mateja Stempelj; Borut Strukelj; Mojca Lunder
Journal:  J Diabetes Investig       Date:  2015-04-29       Impact factor: 4.232

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.